Vanda confirms revised unsolicited takeover proposal from Future Pak at $8.50-$9.00 per share plus CVRs

Vanda Pharmaceuticals Inc.

Future Pak LLC proposes $8.50-$9.00 per share cash plus Contingent Value Rights for Vanda Pharmaceuticals.
Vanda Board will review the revised non-binding proposal with financial and legal advisors.
No shareholder action required at this time; company will not comment further until Board completes review.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.